Provided by Tiger Fintech (Singapore) Pte. Ltd.

TransMedics Group, Inc.

68.53
+4.186.50%
Post-market: 68.00-0.5300-0.77%19:45 EDT
Volume:908.53K
Turnover:61.76M
Market Cap:2.31B
PE:67.85
High:68.79
Open:65.72
Low:65.26
Close:64.35
Loading ...

Company Profile

Company Name:
TransMedics Group, Inc.
Exchange:
NASDAQ
Establishment Date:
1998
Employees:
728
Office Location:
200 Minuteman Road,Suite 302,Andover,Massachusetts,United States
Zip Code:
01810
Fax:
- -
Introduction:
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Directors

Name
Position
James R. Tobin
Chairman of Board of Director
Waleed Hassanein
President, Chief Executive Officer, Director
David Weill
Director
Edward M. Basile
Director
Edwin M. Kania
Director
James Gilbert
Director
Thomas J. Gunderson
Director

Shareholders

Name
Position
Waleed Hassanein
President, Chief Executive Officer, Director
Stephen Gordon
Chief Financial Officer, Treasurer and Secretary
John Carey
Vice President of Operations
John Sullivan
Vice President of Quality and Engineering
Miriam Provost
Vice President of U.S. Regulatory and FDA Relations
Tamer Khayal
Chief Commercial Officer